We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPH icon
2051
VanEck Pharmaceutical ETF
PPH
$985M
$1.02M ﹤0.01%
13,155
+557
+4% +$41.1K
PCYO icon
2052
Pure Cycle
PCYO
$255M
$1.02M ﹤0.01%
+97,501
New +$912K
XLK icon
2053
PUT
State Street Technology Select Sector SPDR ETF
XLK
$109B
$1.02M ﹤0.01%
16,400
-34,000
-67% -$2.16M
AACIW
2054
CALL
DELISTED
Armada Acquisition Corp. I Warrant
AACIW
$1.02M ﹤0.01%
100,000
PRBM.WS
2055
CALL
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
$1.02M ﹤0.01%
100,000
-386,669
-79% -$12.9K
TIL icon
2056
Instil Bio
TIL
$49M
$1.02M ﹤0.01%
80,793
MHO icon
2057
M/I Homes
MHO
$3.95B
$1.02M ﹤0.01%
22,029
-242,295
-92% -$10.4M
ENR icon
2058
Energizer
ENR
$1.47B
$1.01M ﹤0.01%
+30,142
New +$926K
MSPR
2059
DELISTED
MSP Recovery Inc
MSPR
$1.01M ﹤0.01%
144
AEON.WS
2060
CALL
DELISTED
AEON Biopharma Inc
AEON.WS
$1.01M ﹤0.01%
100,330
TWO
2061
Two Harbors Investment
TWO
$1.27B
$1.01M ﹤0.01%
+63,824
New +$959K
QFTA.WS
2062
CALL
DELISTED
Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50
QFTA.WS
$1.01M ﹤0.01%
100,000
ATKR icon
2063
Atkore
ATKR
$2.41B
$1M ﹤0.01%
+8,839
New +$925K
FLYX.WS icon
2064
CALL
flyExclusive Inc Warrants
FLYX.WS
$1,000K ﹤0.01%
100,271
-108,818
-52% -$20.5K
ROVR
2065
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$999K ﹤0.01%
272,238
+152,864
+128% +$655K
SOC.WS
2066
CALL
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$997K ﹤0.01%
99,183
-199,512
-67% -$92.6K
ANGO icon
2067
AngioDynamics
ANGO
$605M
$991K ﹤0.01%
+71,965
New +$1M
CPS icon
2068
Cooper-Standard Automotive
CPS
$517M
$991K ﹤0.01%
109,365
-195,967
-64% -$1.39M
GPC icon
2069
Genuine Parts
GPC
$17.9B
$989K ﹤0.01%
+5,700
New +$992K
ABCL icon
2070
AbCellera Biologics
ABCL
$1.65B
$989K ﹤0.01%
97,600
-256,797
-72% -$2.97M
CIM
2071
Chimera Investment
CIM
$1.06B
$986K ﹤0.01%
+59,768
New +$1.11M
GCO icon
2072
Genesco
GCO
$434M
$980K ﹤0.01%
21,299
-18,210
-46% -$826K
GSBD icon
2073
Goldman Sachs BDC
GSBD
$997M
$980K ﹤0.01%
+71,425
New +$1.07M
EHTH icon
2074
eHealth
EHTH
$41.9M
$972K ﹤0.01%
200,887
-276,680
-58% -$1.03M
MSEX icon
2075
Middlesex Water
MSEX
$1.07B
$969K ﹤0.01%
+12,320
New +$1.07M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.